Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study, Randomized, Multicenter, Evaluating the Efficacy of a Cardiovascular Active Prevention Vs Usual Clinical Practice, on the Morbi-mortality Decrease in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitor

NCT03746054 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT03746054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03746054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study, Randomized, Multicenter, Evaluating the Efficacy of a Cardiovascular Active Prevention Vs Usual Clinical Practice, on the Morbi-mortality Decrease in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitor
Lead sponsor
University Hospital, Angers
Phase
Phase 3
Overall status
Terminated
Start date
December 20, 2019
Completion date
April 16, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia (cml)